Study on the COVID-19 infection status, prevention and control strategies among people entering Shenzhen
- PMID: 33743630
- PMCID: PMC7980727
- DOI: 10.1186/s12889-021-10548-8
Study on the COVID-19 infection status, prevention and control strategies among people entering Shenzhen
Erratum in
-
Correction to: Study on the COVID-19 infection status, prevention and control strategies among people entering Shenzhen.BMC Public Health. 2021 May 12;21(1):898. doi: 10.1186/s12889-021-10895-6. BMC Public Health. 2021. PMID: 33980196 Free PMC article. No abstract available.
Abstract
Background: The novel coronavirus disease 2019 (COVID-19) confirmed cases overseas have continued to rise in the last months, and many people overseas have chosen to return to China. This increases the risk of a large number of imported cases which may cause a relapse of the COVID-19 outbreak. In order to prevent imported infection, the Shenzhen government has implemented a closed-loop management strategy using nucleic acid testing (NAT) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and requiring 14 days of medical observation for individuals with an overseas tour history (Hong Kong, Macao, Taiwan province and other countries). Our study aims to describe the status of COVID-19 infection among people entering Shenzhen, and to evaluate the effect of the closed-loop management strategy.
Methods: We undertook a descriptive study and risk analysis by the entry time, time of reporting, and local confirmed cases in countries of origin. The NAT were completed in Shenzhen Center for Disease Control and Prevention (CDC), ten district-level CDCs, and fever clinics.
Results: A total of 86,844 people from overseas entered Shenzhen from January 1 to April 18, 2020; there were 39 imported COVID cases and 293 close contacts. The infection rate of people entering was 4.49‰ [95% Confidence interval (CI): 3.26‰-6.05‰]. Fourteen imported cases (35.9%) came from the UK, and nine (23.08%) came from the USA. People entering from the USA since March 9 or from the UK since March 13 are the high-risk population. As of July 17, there have been no new confirmed cases in Shenzhen for 153 days, and the numbers of confirmed case, close contacts, and asymptomatic cases are 0.
Conclusions: The closed-loop management has been effective in preventing imported infection and controlling domestic relapse. The distribution of entry time and report time for imported cases overseas was similar. This shows that it is important to implement closed-loop management at the port of entry.
Keywords: COVID-19; Closed-loop management; Imported cases; Prevention and control; SARS-CoV-2.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures










Similar articles
-
Epidemiological Characteristics of COVID-19 and Effective Public Health Interventions in Shenzhen, China.Front Public Health. 2022 Jun 30;10:923175. doi: 10.3389/fpubh.2022.923175. eCollection 2022. Front Public Health. 2022. PMID: 35844887 Free PMC article.
-
To halt the spread of imported coronavirus disease 2019 cases in China: Action and challenges.Travel Med Infect Dis. 2021 Jan-Feb;39:101913. doi: 10.1016/j.tmaid.2020.101913. Epub 2020 Nov 7. Travel Med Infect Dis. 2021. PMID: 33171285 Free PMC article. No abstract available.
-
Assessing the effectiveness of travel control measures in preventing imported COVID-19 cases reveals the critical role of travel volume.Epidemics. 2025 Jun;51:100837. doi: 10.1016/j.epidem.2025.100837. Epub 2025 May 15. Epidemics. 2025. PMID: 40398087
-
COVID-19 imported cases and severity: expected information from genomic characterization of SARS-CoV-2 strains in Mozambique.J Infect Dev Ctries. 2021 Dec 31;15(12):1792-1800. doi: 10.3855/jidc.14316. J Infect Dev Ctries. 2021. PMID: 35044934 Review.
-
In-flight transmission of wild-type SARS-CoV-2 and the outbreak potential of imported clusters of COVID-19: a review of published evidence.Global Health. 2021 Aug 21;17(1):93. doi: 10.1186/s12992-021-00749-6. Global Health. 2021. PMID: 34419084 Free PMC article. Review.
Cited by
-
The governance of imported 2019-nCov infections: What can be learned from China's experience?Glob Health Res Policy. 2022 Mar 9;7(1):8. doi: 10.1186/s41256-022-00243-5. Glob Health Res Policy. 2022. PMID: 35264241 Free PMC article.
-
Implementation and challenges to preventing the re-establishment of malaria in China in the COVID-19 era.Global Health. 2022 Jun 21;18(1):64. doi: 10.1186/s12992-022-00858-w. Global Health. 2022. PMID: 35729642 Free PMC article.
-
Could mouth rinses be an adjuvant in the treatment of SARS-CoV-2 patients? An appraisal with a systematic review.Int J Dent Hyg. 2022 Feb;20(1):136-144. doi: 10.1111/idh.12555. Epub 2021 Oct 29. Int J Dent Hyg. 2022. PMID: 34628705 Free PMC article.
-
Correction to: Study on the COVID-19 infection status, prevention and control strategies among people entering Shenzhen.BMC Public Health. 2021 May 12;21(1):898. doi: 10.1186/s12889-021-10895-6. BMC Public Health. 2021. PMID: 33980196 Free PMC article. No abstract available.
References
-
- WHO . Novel coronavirus (2019-NCoV) situation report 1. Geneva: World Health Organization; 2020.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous